Gary Speier Email & Phone Number

Minneapolis, Minnesota, Us

My practice focuses on ANDA Hatch Waxman generic drug IP litigation, pre-suit investigations, post grant proceedings (e.g., inter partes review), freedom to operate (FTO), and due diligence. I am currently counsel to a number of leading generic drug companies, including those who are first-to-file with an ANDA with a Paragraph IV Certification, and thus eligible for 180-days of market exclusivity.BAR ADMISSIONS/CERTIFICATIONS:• Certified Licensing Professional (CLP), Licensing Executives Society (LES®) (Credential ID: 1400)• United States Patent Office (Reg. No. 45,458)• Supreme Court of the United States (Bar #: 315255)• United States Court of Appeals for the Federal Circuit• United States District Court for the District of Minnesota• United States District Court for the District of New Jersey• United States Court of Appeals for the Eighth Circuit• Minnesota (Lawyer ID: 029276X; Active)• Pennsylvania (Lawyer ID: 80345; Inactive)• New Jersey (Attorney ID: 034411997; Active)• North Dakota (Bar ID: 07083; Inactive)

GNPS Laboratories, LLC (“GNPS”) is a privately held pharmaceutical company with a principal location in Minnesota. With an FDA inspected pharmaceutical development and clinical facility (owned and operated by co-founding owner Paul Sudhakar) located outside of Kansas City, KS, the company focuses on identifying, developing, and out-licensing niche drug products—505(b)(2)s and P-IV ANDAs—on its own, in partnerships with other drug companies, or as fee for service programs. The products span a wide-range of therapeutic indications and dosage forms. GNPS is owned by the two founders, Gary Speier and Paul Sudhakar.

Minneapolis, Mn, Us

TITLE/POSITION:2003–2016, Principal (Partner)1998–2003, Associate2009–2012, Board of DirectorsMANAGEMENT RESPONSIBILITIES:▪ Case Management Group (CMG) supervisor (2000–2001)▪ Hiring Attorney (2001–2009)▪ Operations Committee (2006–2016)SUMMARY:Procurement (domestic, international, and foreign) of patents, including preparation of patent applications, amendments, responses to office actions, and appeal briefs in the fields of chemistry, pharmaceuticals, biotechnology, and medical devices. Practice also includes Hatch Waxman (ANDA) patent litigation, as well as opinion work and counseling of clients on issues of patentability, infringement liability, and freedom to operate. Extensive client interactions on issues of licensing, business development, commercial potential of new technologies, IP valuation, and developing legal/patent strategies for maintaining IP portfolios. Training and supervision of law clerks and associates. Represent large-cap, mid-cap, small-cap, startup, nonprofit, solo inventor, and private equity & venture capital clients.Selected by Super Lawyers as a Rising Star (2004).

Seattle, Wa, Us

Patent attorney in the chemical and pharmaceutical areas at Seed & Berry (now The Seed IP Law Group).

Brentford, Middlesex, Gb

Law clerk in pharmaceutical patent law for SmithKline Beecham (now Glaxo SmithKline).

Research involved a protein engineering project that attached peptides and peptide mimetics to synthetic organic moieties to form novel, non naturally-occurring protein structures. Combined peptide synthesis with classical organic chemistry and computer modeling of protein structures. Research involved the design and synthesis of candidate inhibitors of the cysteine protease enzyme, Interleukin-1-ß Converting Enzyme (ICE), for the treatment of chronic inflammatory diseases.

Doctor Of Law (J.D.)

Master Of Science (M.Sc.), Synthetic Organic Chemistry

Master Of Science - Ms, Finance (Msf)

Master Of Business Administration (Mba) (Finance Focus), Finance • Accounting • Economics • Strategic Management

Bachelor Of Science (B.Sc.), Chemistry

High School

Grammar School

Grammar School